The southeast Asian nation launched a national vaccination campaign against COVID-19 in February 2021, with China being the key vaccine supplier and most of the vaccines used in the kingdom are Sinovac and Sinopharm. Vandine said vaccines are an effective tool to protect lives from the attack ...
Wang Junzhi, an expert from the vaccine research and development working group under the State Council's inter-agency task force, said that the data from animal tests and human clinical trials during vaccine research and development showed that China's COVID-19 vaccines meet the national standards...
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has elicited an equally rapid response aiming to develop a COVID-19 vaccine. These efforts are encouraging; however, comprehensive efficacy and safety evaluations are e
said that the data from animal tests and human clinical trials during vaccine research and development showed that China's COVID-19 vaccines meet the national standards in both safety and effectiveness.
China continues to speed up its inoculation drive to approve the emergency use of COVID-19 vaccines for those aged between 3 and 17 years old. CGTN's Liu Yang talked with the company's Vice President Zhang Yuntao about the vaccine's safety and efficacy....
Most COVID-19 vaccines being rolled out worldwide are for adults, who are at higher risk from the coronavirus. Pfizer's vaccine is authorized for ages 16 and older. But vaccinating children of all ages will be critical to stopping the pandemic - and helping schools, at least the upper gra...
More than 9 million doses of COVID-19 vaccines have been administered across China, and the safety and efficacy of the vaccines have been proved, a top health official said.
EU regulators declared the AstraZeneca Covid-19 vaccine "safe and effective" on Thursday (18 March). The announcement by the European Medicines Agency (EMA) came after 13 member states suspended its use over blood clot fears. But Dr Emer Cook, who heads the agency, told reporters that the...
The development of a safe and effective RSV vaccine has been elusive thus far. The intramuscularly administered formalin-inactivated RSV (FI-RSV) vaccine enhanced illness in infants with natural RSV infection; this phenomenon was replicable in animal models and named vaccine-enhanced disease (VED) ...
The outbreak of the novel SARS〤oVpathogen and corresponding coronavirus disease 2019 (COVID) have had an enormous impact on both global health and the daily lives of billions of people worldwide. With a proven vaccine at least a year from being fully tested for safety and efficacy, there ...